CNB
LXRX icon

City National Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History

City National Bank’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,856
Closed -$48K – 900
2014
Q3 		$48K Sell
4,856
-340
-7% -$3.63K ﹤0.01% 884
2014
Q2 		$59K Sell
5,196
-78,340
-94% -$841K ﹤0.01% 877
2014
Q1 		$1.01M Buy
83,536
+38,356
+85% +$490K 0.01% 413
2013
Q4 		$569K Buy
45,180
+21,539
+91% +$343K 0.01% 537
2013
Q3 		$394K Buy
+23,641
New +$396K 0.01% 550

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

City National Bank's LXRX Position: Q4 2014 in Review

City National Bank sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2014, closing a stake of 4,856 shares — an estimated $48K sold.

City National Bank first reported a position in LXRX in Q3 2013 and held it in 5 quarters. The position peaked at $1.01M in Q1 2014. 123 funds tracked by Wall St. Rank hold LXRX as of Q4 2014.

  • City National Bank reported no remaining Lexicon Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • City National Bank sold 4,856 Lexicon Pharmaceuticals shares in Q4 2014, an estimated $48K.
  • City National Bank first reported a position in Lexicon Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • City National Bank's Lexicon Pharmaceuticals position peaked at $1.01M in Q1 2014.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2014.

Based on City National Bank's 13F filing for Q4 2014, filed 30 Jan 2015.